Retrieve available abstracts of 63 articles: HTML format
Single Articles
July 2025
HIRANO K, Ikenoue T, Seki T, Komukai S, et al Development and validation of personalized risk prediction models for patients
with IgA nephropathy: a nationwide multicenter cohort study.
J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02338. PubMedAbstract available
June 2025
DECAESTECKER A, Daniel A, Malbranque Z, Wayolle N, et al Crescentic glomerulonephritis associated with myelodysplatic syndrome and
visceral leishmaniasis.
J Nephrol. 2025 Jun 19. doi: 10.1007/s40620-025-02329. PubMedAbstract available
GOGGINS E, DeLaat A, Barr B, Taliercio J, et al Clinical uptake of an antigen-based approach to membranous nephropathy: a survey
of general nephrologists and glomerular disease experts.
J Nephrol. 2025 Jun 11. doi: 10.1007/s40620-025-02313. PubMedAbstract available
May 2025
ISHIGAKI S, Takei H, Hiramoto K, Kaneko Y, et al Plasma cell-rich interstitial nephritis without glomerulonephritis in
granulomatosis with polyangiitis.
J Nephrol. 2025 May 30. doi: 10.1007/s40620-025-02318. PubMed
April 2025
MATHEW GG Molecular markers or clinical end points? What is the optimal monitoring tool for
low-dose rituximab in membranous nephropathy in resource-limited settings?
J Nephrol. 2025 Apr 7. doi: 10.1007/s40620-025-02273. PubMedAbstract available
TANG C, Si FL, Chen P, Hou WY, et al Effectiveness and safety of finerenone in non-diabetic patients with IgA
nephropathy.
J Nephrol. 2025 Apr 1. doi: 10.1007/s40620-025-02240. PubMed
March 2025
XU L, Wu C, Li G Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic
review.
J Nephrol. 2025 Mar 26. doi: 10.1007/s40620-025-02261. PubMedAbstract available
CLAUDIO P, Gabriella M Targeting autophagy in autoimmune glomerular diseases.
J Nephrol. 2025 Mar 19. doi: 10.1007/s40620-025-02267. PubMedAbstract available
MAHMOUD NB, Sahtout W, Ghabi F, Salem MB, et al Prognostic value of C3-exclusive deposits in post-infectious glomerulonephritis
in adults: an observational cohort in Tunisia.
J Nephrol. 2025 Mar 7. doi: 10.1007/s40620-025-02262. PubMed
BONELLI GD, Sciascia S, Calatroni M, L'imperio V, et al Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a
multicentre Italian cohort.
J Nephrol. 2025;38:643-653. PubMedAbstract available
EISINGER F, Neumann M, Worn M, Fritsche A, et al Comparison of GFR estimation in patients with diabetes mellitus using the EKFC
and CKD-EPI equations.
J Nephrol. 2025;38:707-716. PubMedAbstract available
February 2025
SRIDHARAN K, Gopal B, Wilson S, Pham A, et al Obinutuzumab in Rituximab-resistant and recurrent membranous nephropathy: a
case-series.
J Nephrol. 2025 Feb 20. doi: 10.1007/s40620-025-02224. PubMedAbstract available
UMEZAWA Y, Aoki R, Ichikawa D, Suzuki Y, et al Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage
staining in secondary IgA nephropathy associated with alcoholic cirrhosis.
J Nephrol. 2025 Feb 13. doi: 10.1007/s40620-025-02213. PubMedAbstract available
January 2025
KANG D, Zhang M, Chen Z, Zheng Z, et al Clinicopathological characteristics and prognosis of lupus nephritis patients
with positive anti-ribonucleoprotein antibodies.
J Nephrol. 2025 Jan 20. doi: 10.1007/s40620-024-02177. PubMedAbstract available
December 2024
JAFRY NH, Butt N, Mubarak M, Akhtar SF, et al Anti-glomerular basement membrane disease complicated by malaria during pregnancy
with successful maternal and fetal outcomes: a case report.
J Nephrol. 2024;37:2655-2660. PubMedAbstract available
November 2024
YANG M, Liu X, Chen Y, Chen X, et al Validation and modification of renal risk score for prediction of long-term
kidney survival in patients with MPO-ANCA-associated glomerulonephritis.
J Nephrol. 2024 Nov 22. doi: 10.1007/s40620-024-02134. PubMedAbstract available
KANBAY M, Ozbek L, Guldan M, Copur S, et al Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant
medicine.
J Nephrol. 2024 Nov 20. doi: 10.1007/s40620-024-02149. PubMedAbstract available
QUEYREL-MORANNE V, Daniel L, Moranne O Focal segmental glomerulosclerosis in a native African patient with systemic
lupus erythematosus.
J Nephrol. 2024 Nov 12. doi: 10.1007/s40620-024-02106. PubMed
October 2024
ELAHI T, Ahmed S, Ahmed E, Mubarak M, et al Clinicopathological characteristics and outcomes of adult patients with
idiopathic membranoproliferative glomerulonephritis according to an
immunofluorescence-based classification.
J Nephrol. 2024 Oct 14. doi: 10.1007/s40620-024-02083. PubMedAbstract available
ZHANG Q, Zhou F, Zhao Y, Luo C, et al The uncertain correlation of ANCAs in patients with lupus nephritis and
crescents, an experience from Chinese centers.
J Nephrol. 2024 Oct 10. doi: 10.1007/s40620-024-02085. PubMedAbstract available
BARAGETTI I, Del Vecchio L, Ferrario F, Alberici F, et al The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life
Italian cohort.
J Nephrol. 2024 Oct 6. doi: 10.1007/s40620-024-02071. PubMedAbstract available
HERNANDEZ-ANDRADE A, Nordmann-Gomes A, Juarez-Cuevas B, Zavala-Miranda MF, et al Urine epidermal growth factor as a biomarker for kidney function recovery and
prognosis in glomerulonephritis with severe kidney function impairment.
J Nephrol. 2024 Oct 4. doi: 10.1007/s40620-024-02068. PubMedAbstract available
July 2024
YANG T, Shi Y, Wang Y, Feng Y, et al Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA
nephropathy.
J Nephrol. 2024 Jul 24. doi: 10.1007/s40620-024-02029. PubMedAbstract available
BALTU D, Serin O, Aksu T, Hizarcioglu Gulsen H, et al Membranoproliferative glomerulonephritis in a patient with lysinuric protein
intolerance: lesson for the clinical nephrologist.
J Nephrol. 2024 Jul 17. doi: 10.1007/s40620-024-02018. PubMed
PERNA A, Campise M, Alfieri CM, Regalia A, et al Kidney transplantation in patients with ANCA-associated vasculitis is associated
with a high incidence of post-transplant cancer.
J Nephrol. 2024;37:1611-1619. PubMedAbstract available
June 2024
SARA M, Anna S, Lorenzo B, Valentina B, et al Macrophage activation syndrome secondary to systemic lupus erythematosus: lesson
for the clinical nephrologist.
J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-01997. PubMed
RATNAYAKE C, Crombie T, Fraenkel M, McMahon LP, et al Haemoptysis in a stable kidney transplant patient previously seropositive for
anti-GBM and ANCA glomerulonephritis.
J Nephrol. 2024 Jun 18. doi: 10.1007/s40620-024-01993. PubMed
LIM RS, Yeo SC EXternal validation of international IgA nephropathy prediction tool in a
Singapore CohorT (EXIST Study).
J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01985. PubMed
LIU L, de Leeuw K, der Meer BD, van Goor H, et al Expression of myxovirus resistance protein A in lupus nephritis and other
glomerular nephropathies.
J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01971. PubMed
CUGNO M, Mancuso MC, Depetri F, Peyvandi F, et al IgM autoantibodies to complement factor H in C3 glomerulopathy.
J Nephrol. 2024 Jun 1. doi: 10.1007/s40620-024-01961. PubMed
May 2024
NAGARAJAH S, Saleh QW, Rasmussen M, Tepel M, et al Long non-coding RNA MGAT3 in kidney transplant recipients with immunoglobulin A
nephropathy.
J Nephrol. 2024;37:1133-1135. PubMed
CETINKAYA H, Gursu M, Yazici H, Cebeci E, et al Could mesangial C3 deposition be an independent prognostic marker in
immunoglobulin A nephropathy?
J Nephrol. 2024;37:923-932. PubMedAbstract available
April 2024
DAVIES E, Chetwynd A, McDowell G, Rao A, et al The current use of proteomics and metabolomics in glomerulonephritis: a
systematic literature review.
J Nephrol. 2024 Apr 30. doi: 10.1007/s40620-024-01923. PubMedAbstract available
SHAHEEN M, Bharat A, Friedman AN, Guo S, et al ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis,
membranous nephropathy and diabetic kidney disease: a case report and literature
review.
J Nephrol. 2024 Apr 17. doi: 10.1007/s40620-024-01924. PubMedAbstract available
March 2024
ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al Class V lupus nephritis recurrence with histologic resolution in a kidney
transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson
for the clinical nephrologist.
J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920. PubMed
HU D, Wang Z, Wang S, Li Y, et al Lymphatic vessels in patients with crescentic glomerulonephritis: association
with renal pathology and prognosis.
J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903. PubMedAbstract available
REN W, Sun J, Zhang L, He W, et al Significance of the total renal chronicity score in predicting renal outcome in
PLA2R-associated membranous nephropathy.
J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893. PubMedAbstract available
ARNAERT S, Schepens N, Deleu L, Malfait T, et al Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892. PubMedAbstract available
VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al Examining the association between serum galactose-deficient IgA1 and primary IgA
nephropathy: a systematic review and meta-analysis.
J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874. PubMedAbstract available
February 2024
CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al The prognostic value of two histopathologic classification models of
ANCA-associated glomerulonephritis: a prospective study.
J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855. PubMedAbstract available
OCHIAI S, Kikuchi M, Kaikita K, Fujimoto S, et al Rapidly progressive glomerulonephritis due to IgA nephropathy accompanied by
collagenofibrotic glomerulopathy. A nephrology picture.
J Nephrol. 2024 Feb 6. doi: 10.1007/s40620-023-01875. PubMed
January 2024
TRIMARCHI H, Fervenza FC, Coppo R Points of view in nephrology: personalized management of IgA nephropathy, beyond
KDIGO.
J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833. PubMedAbstract available
HE WJ, Wang J, Liu N, Li GY, et al The efficacy and safety of hydroxychloroquine versus leflunomide in patients with
IgA nephropathy: a single-center experience.
J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01839. PubMedAbstract available
December 2023
SCHENA FP, Cox SN Correction to: Is it time for personalized therapy in IgA nephropathy patients?
J Nephrol. 2023 Dec 8. doi: 10.1007/s40620-023-01861. PubMed
BOUSSETTA A, Jellouli M, Hajji M, Rekaya S, et al A membranous nephropathy in a 5 year-old boy: and if that's not all? A
nephrology quiz.
J Nephrol. 2023 Dec 6. doi: 10.1007/s40620-023-01821. PubMed
November 2023
ALBERTAZZI V, Fontana F, Giberti S, Aiello V, et al Primary membranous nephropathy in the Italian region of Emilia Romagna: results
of a multicenter study with extended follow-up.
J Nephrol. 2023 Nov 13. doi: 10.1007/s40620-023-01803. PubMedAbstract available
BANJONGJIT A, Thammathiwat T, Townamchai N, Kanjanabuch T, et al SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody
(ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case
reports.
J Nephrol. 2023 Nov 6. doi: 10.1007/s40620-023-01777. PubMedAbstract available
RUSSWURM M, Kortus-Goetze B, Maier-Giebing T, Groene HJ, et al General prognostic models may neglect vulnerable subgroups in ANCA-associated
vasculitis.
J Nephrol. 2023;36:2269-2280. PubMedAbstract available
GOTO K, Imaizumi T, Hamada R, Ishikura K, et al Renal pathology in adult and paediatric population of Japan: review of the Japan
renal biopsy registry database from 2007 to 2017.
J Nephrol. 2023;36:2257-2267. PubMedAbstract available
XIONG L, Liu L, Tao Y, Guo H, et al Clinical significance of IgM and C3 deposition in children with primary
immunoglobulin A nephropathy.
J Nephrol. 2023;36:2213-2222. PubMedAbstract available
RAO IR, Kolakemar A, Shenoy SV, Prabhu RA, et al Hydroxychloroquine in nephrology: current status and future directions.
J Nephrol. 2023;36:2191-2208. PubMedAbstract available
SCURT FG, Hirschfeld V, Ganz M, Mertens PR, et al Low levels of complement factor C3 at diagnosis can predict outcome in
antineutrophil antibody associated vasculitis.
J Nephrol. 2023;36:2281-2293. PubMedAbstract available
WANG F, Jin Y, Zhou F, Luo L, et al Urinary isomorphic red blood cells for the prediction of disease severity and
renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
J Nephrol. 2023;36:2295-2304. PubMedAbstract available
ROCCATELLO D, Careddu A, Ferro M, Naretto C, et al The steroid-sparing effects of a mycophenolate mofetil-based regimen in the
management of immunoglobulin A nephropathy in patients with histologically active
lesions: A comparison with a control cohort receiving conventional therapy.
J Nephrol. 2023;36:2223-2231. PubMedAbstract available
ALVAREZ L, Kambham N, Su R Renal improvement and remission in a patient with refractory ANCA-associated
vasculitis treated with avacopan.
J Nephrol. 2023;36:2365-2370. PubMedAbstract available
October 2023
LIU Z, Wan C, Cao Y, Liu S, et al Distribution spectrum and clinical significance of glomerular exostosin (EXT1)
deposits in PLA2R-positive membranous nephropathy.
J Nephrol. 2023 Oct 26. doi: 10.1007/s40620-023-01779. PubMedAbstract available
PALA C, Parenti E, Vizzini G, Gianfreda D, et al Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful
treatment with eculizumab.
J Nephrol. 2023 Oct 17. doi: 10.1007/s40620-023-01789. PubMedAbstract available
MONGERA N, Passler W, Sethi S, Kozakowski N, et al A case of protocadherin FAT1-positive membranous nephropathy secondary to
hematopoietic stem-cell transplantation.
J Nephrol. 2023 Oct 10. doi: 10.1007/s40620-023-01786. PubMed
September 2023
PAOLO SF, Natasha CS Is it time for personalized therapy in IgA nephropathy patients?
J Nephrol. 2023 Sep 22. doi: 10.1007/s40620-023-01745. PubMed
AI S, Yan X, Zhao X, Ye W, et al Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
J Nephrol. 2023 Sep 15. doi: 10.1007/s40620-023-01751. PubMedAbstract available
BAIER E, Kluge IA, Hakroush S, Tampe B, et al Low hemoglobin levels are associated with Bowman's capsule rupture and
peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular
injury to anemia?
J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748. PubMedAbstract available
DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the
pathogenesis of IgA nephropathy.
J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764. PubMed
June 2023
WATANABE H, Yamana H, Okada A, Matsui H, et al Therapeutic plasma exchange for anti-glomerular basement membrane disease with
dialysis-dependent kidney failure without diffuse alveolar hemorrhage.
J Nephrol. 2023 Jun 24. doi: 10.1007/s40620-023-01695. PubMedAbstract available